Skip to main content

The Children’s Mercy Research Institute

A Research Center for Children

The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with multidisciplinary teams at the point of care while bringing together nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation.

As a result, we accelerate the development of groundbreaking individualized therapies and treatments that transform the potential of all children, one child at a time. 

THE CHILDREN'S MERCY RESEARCH INSTITUTE NEWS

Dr. Keith August Receives ‘Hyundai Hope on Wheels’ Grant to Support Cancer Research

Dr. August said, “Here at Children’s Mercy Kansas City we are deeply committed to providing access to the newest and most exciting treatments for children with cancer.  This grant goes a long way to helping to provide the infrastructure necessary to have more than 50 clinical trials open, including many phase 1 and 2 trials that require a lot of additional work that often does not get supported."

Read more about the research
Gift box icon

Make a Gift

Donors like you help support the research discoveries of tomorrow.

Join us!

We are looking for volunteers to be a part of the Family and Community Research Advisory Board.

Genomic Answers for Kids

Thousands of genetic diseases affecting children remain undiscovered and untreatable. But hope is on the horizon with Genomic Answers for Kids, a first-of-its-kind pediatric data repository to find novel treatments for pediatric genetic conditions.

Discover more
Researcher at Children's Mercy

The CMRI’s Commitment to Inclusion and Diversity

Inclusion and diversity among research teams, participants, families, vendors and community partners is essential to fulfilling our mission to improve the health and wellbeing of children everywhere.

Discover more
Colorful graphic of a molecule

Researcher Network

Learn about the dynamic research programs and explore potential collaborations with our world-renown investigators.